ArticleFrontiers in immunology2024

A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL.

Laure Ricard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.